Cardiotrophin-1 induces intercellular adhesion molecule-1 expression by nuclear factor κB activation in human umbilical vein endothelial cells

Chinese Medical Journal

Volumn 121, Issue 24, 2008, Pages 2592-2598

  Fritzenwanger, Michael ^a   Foerster, Martin ^a   Meusel, Katharina ^a   Jung, Christian ^a   Figulla, Hans R ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Cardiotrophin 1; Human umbilical vein endothelial cells; Intercellular adhesion molecule 1; Nuclear factor B

Indexed keywords

CARDIOTROPHIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PARTHENOLIDE; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CELL CULTURE; CELL STIMULATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HYPOTHESIS; PATHOGENESIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SUPERNATANT; UMBILICAL VEIN; WESTERN BLOTTING;

EID: 60649089311     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200812020-00022     Document Type: Article

References (47)

1. Pennica D, King KL, Shaw KJ, Luis E, Rullamas J, Luoh SM, et al. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci U S A 1995; 92: 1142-1146.
2. Wollert KC, Taga T, Saito M, Narazaki M, Kishimoto T, Glembotski CC, et al. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gpl30/leukemia inhibitory factor receptor- dependent pathways. J Biol Chem 1996; 271: 9535-9545.
3. Pennica D, Shaw KJ, Swanson TA, Moore MW, Shelton DL, Zioncheck KA, et al. Cardiolrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem 1995; 270: 10915-10922.
4. Sheng Z, Permita D, Wood WI, Chien KR. Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survival. Development 1996; 122: 419-428.
5. Freed DH, Cunnington RH, Dangerfield AL, Sutton JS, Dixon IM. Emerging evidence for the role of cardiotrophin-1 in cardiac repair in the infarcted heart, Cardiovasc Res 2005; 65: 782-792.
6. Talwar S, Squire IB, O'Brien RI, Donna PF, Davies GUY, Ng LL. Plasma cardiotrophin-1 following acute myocardial infarction: relationship with left ventricular systolic dysfunction. Clin Sci (Lond) 2002; 102: 9-14.
7. Jougasaki M, Leskinen H, Larsen AM, Luchner A, Cataliotti A, Tachibana I, et al. Ventricular cardiotrophin-1 activation precedes BNP in experimental heart failure. Peptides 2003; 24: 889-892.
8. Ng IL, O'Brien RJ, Demme B, Jennings S. Non-competitive immunochemilummometric assay for cardiotrophin-1 detects elevated plasma levels in human heart failure. Clin Sci (Lond) 2002; 102: 411-416.
9. Lesbordes JC, Bordet T, Hist G, Castelnau-Ptakhine L, Rouhani S, Gilgenkrantz H, et al. In vivo electrotransfer of the cardiotrophin-1 gene into skeletal muscle slows down progression of motor neuron degeneration in pmn mice. Hum Male Genet 2002; 11: 1615-1625.
10. Jean H, Yang R, Keller GA, Ryan A, Ko A, Finkle D, et al. In vivo effects of cardiotrophin-1. Cytokin 1996; 8: 920-926.
11. Heinrich PC, Behrmann I, Muller-Newen G; Schaper F, Graeve L. Interleukin-6-type cytokin signalling through the gpl30/Guaiac/STAT pathway. Biochem J 1998; 334: 297-314.
12. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003; 374: 1-20.
13. Sheng Z, Knowlton K, Conn J, Hoshijima M, Brown JH, Chien KR. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy. J Biol Chem 1997; 272: 5783-5791.
14. SOLVD. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart 5 failure. The SOLVD Investigators. N Engl J Med 1991; 325: 293-302.
15. Libby J, Suldaova G, Lee RAYED, Galis ZS. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol 1995; 25: S9-S12.
16. Li H, Cybulsky MI, Gimbrone MA, Libby P. Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. Am J Pathol 1993; 143: 1551-1559.
17. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J 1994; 8: 504-512.
18. Gearing J, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 14: 506-512.
19. Poilus WJ. How are cytokines activated in heart failure? Uar J Heart Fail 1999; 1:309-312
20. Mama DL. Mechanisms and models in heart failure: A combinatorial approach. Circulation 1999; 100: 999-1008.
21. Kapadia S, Dibbs Z, Kurrelmeyer K, Kalra D, Seta Y, Wang F, et al. The role of cytokines in the failing human heart. Cardiol Clin 1998; 16: 645-656.
22. Seta Y, Sheen K, Bozkurt B, Oral H, Mann DL. Basic mechanisms in heart failure: the cytokine hypothesis. J Card Fail 1996; 2: 243-249.
23. Herskowitz A, Ahmed-Ansari A, Neumann DA, Beschomer WE, Rose NR, Soule LM, et al. Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: a nonhistologic marker of myocarditis. J Am Coll Cardiol 1990; 15: 624-632.
24. Ino T, Kishiro M, Okubo M, Akimoto K, Nishimoto K, Yabuta K, et al. Late persistent expressions of ICAM-1 and VCAM-1 on myocardial tissue in children with lymphocytic myocarditis. Cardiovasc Res 1997; 34: 323-328.
25. Wojnicz R, Nowalany-Kozielska E, Wodniecki J, Szczurek-Katanski K, Nezynski J, Zembala M, et al. Immunohistological diagnosis of myocarditis. Potential role of sarcolemmal induction of the MHC and ICAM-1 in the detection of autoimmune mediated myocyte injury. Uar Heart J 1998; 19: 1564-1572.
26. Mahon NG; Madden BP, Caforio AL, Elliott PM, Haven J, Keogh BE, et al. Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy. J Am Coll Cardiol 2002; 39: 455-462.
27. Devaux B, Scholz D, Hirche A, Klovekorn WP, Schaper J. Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. Uar Heart J 1997; 18: 470-479.
28. Takahashi M, Ikeda U, Masuyama J, Kitagawa S, Kasahara T, Saito M, et al. Involvement of adhesion molecules in human monocyte adhesion to and transmigration through endothelial cells in vitro. Atherosclerosis 1994; 108: 73-81.
29. Yin WH, Conn JW, Jen HL, Chiang MC, Huang WP, Feng AN, et al. The prognostic value of circulating soluble cell adhesion molecules in patients with chronic congestive heart failure. Uar J Heart Fail 2003; 5: 507-516.
30. Roebuck KA, Finnegan A. Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J Leukoc Biol 1999; 66: 876-888.
31. Dinarello CA. Proinflammatory cytokines. Chest 2000; 118: 503-508.
32. Mann DL, Young JB. Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Chest 1994; 105: 897-904.
33. Abbas AK, Lichlmann AH, Pober JS. Cytokines. In: Abbas AK, Lichtmann AH, Pober JS, eds. Cellular and molecular immunology. Philadelphia: WB Saunders; 1991: pp 225-243.
34. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-241.
35. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, et al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 1996; 93: 704-711.
36. Habib FM, Springall DR, Davies GJ, Oaldey CM, Yacoub MH, Polak JM. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 1996; 347: 1151-1155.
37. Adamopoulos S, Parissis JT, Kremastinos DT. A glossary of circulating cytokines in chronic heart failure. Uar J Heart Fail 2001; 3: 517-526.
38. Wilhelmi MH, Leyh RG, Wilhelmi M, Haverich A. Upregulation of endothelial adhesion molecules in hearts with congestive and ischemic cardiomyopathy: immunohistochemical evaluation of inflammatory endothelial cell activation. Uar J Cardiothorac Surg 2005; 27: 122-127.
39. Tousoulis D, Homaei H, Ahmed N, Asimakopoulos G, Zouridakis E, Toutouzas P, et al. Increased plasma adhesion molecule levels in patients with heart failure who have ischemic heart disease and dilated cardiomyopathy. Am Heart J 2001; 141: 277-280.
40. Noutsias M, Hohmann C, Pauschinger M, Schwimmbeck PL, Ostermann K, Rode U, et al. sICAM-1 correlates with myocardial ICAM-1 expression in dilated cardiomyopathy, Int J Cardiol 2003; 91: 153-161.
41. Parissis JT, Karavidas A, Bistola V, Arapi S, Paraskevaidis IA, Farmakis D, et al. Effects of levosimendan on flow-mediated vasodilation and soluble adhesion molecules in patients with advanced chronic heart failure. Atherosclerosis 2008; 197: 278-282.
42. Wang XM, Li Y, Li HF, Leo F, Jia GL. Effects of perindopril on soluble interceltular adhesion molecule-1 in patients with congestive heart failure. Heart 2002; 88: 417.
43. Ichiki T, Jougasaki M, Setogucbi M, Imamura J, Nakashima H, Matsuoka T, et al. Cardiotrophin-1 stimulates intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human aortic endothelial cells. Am J Physiol Heart Circ Physiol 2008; 294: H750-H763.
44. Asai S, Saito Y, Kuwahara K, Mizuno Y, Yoshimura M, Higashikubo C, et al. The heart is a source of circulating cardiotrophin-1 in humans. Biochem Biophys Res Commun 2000; 279: 320-323.
45. Natal C, Fortuno MA, Restituto P, Bazan A, Colina I, Dose J, et al. Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome. Am J Physiol Endocrinol Metab 2008; 295: E52-E60.
46. Cornelius LA, Taylor JT, Degitz K, Li LJ, Lawley TJ, Caughman SW. A 5′ portion of the ICAM-1 gene confers tissue-specific differential expressinn levels and cytokine responsiveness. J Invest Dermatol 1993; 100: 753-758.
47. Zhou Z, Connell MC, MacEwan DJ. TNFRl-induced NF-kappaB, but not ERK, p38MAPK or JNK activation., mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells. Cell Signal 20087; 19: 1238-1248.